# IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
> **ANDA210676** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2019-02-14
## Drug
- **FDA Application Number:** ANDA210676
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
- **Generic name:** DIPHENHYDRAMINE HCL AND IBUPROFEN
- **Active ingredients:** DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurohealth LLC
- **First approval:** 2019-02-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210676)
---
*AI Analytics · CC0 1.0*